Literature DB >> 20488939

Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis.

Annele Sainio1, Tiina Jokela, Markku I Tammi, Hannu Järveläinen.   

Abstract

Changes in the extracellular matrix organization within vascular walls are critical events in the process of atherosclerosis including diabetic macroangiopathy. Here, we examined whether glucose can directly modulate connective tissue reorganization by human vascular smooth muscle cells (VSMCs). Using a collagen gel contraction (CGC) assay, we demonstrated that in comparison with normal glucose concentration (5 mM), high glucose concentration (25 mM) inhibits the efficacy of VSMCs to contract collagen gels. With human genome microarrays, we showed a significant increase in the expression of hyaluronan synthase 2 (HAS2) by VSMCs in hyperglycemic conditions. The finding was verified with quantitative real-time polymerase chain reaction, which also revealed that the expression of the other hyaluronan synthesizing enzymes, HAS1 and HAS3, was stimulated concomitantly. A corresponding increase was observed in hyaluronan (HA) production. Treatment of VSMCs either with hyaluronidase or with 4-methylumbelliferone, an inhibitor of HA synthesis, partially restored the diminished CGC efficacy of VSMCs in hyperglycemic conditions. In conclusion, high glucose concentration stimulated HA synthesis by VSMCs and modulated their ability to reorganize collagen-rich matrix. Because HA is known to enhance the development of atherosclerosis and restenosis after percutaneous coronary interventions, our study provides a new potential mechanism whereby hyperglycemia leads to disturbed vascular remodeling in diabetic patients through stimulation of HA synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488939     DOI: 10.1093/glycob/cwq076

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

Review 1.  Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.

Authors:  Kenneth L Kramer
Journal:  Semin Cell Dev Biol       Date:  2010-07-03       Impact factor: 7.727

Review 2.  Biology and biotechnology of hyaluronan.

Authors:  Manuela Viola; Davide Vigetti; Evgenia Karousou; Maria Luisa D'Angelo; Ilaria Caon; Paola Moretto; Giancarlo De Luca; Alberto Passi
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

Review 3.  The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation.

Authors:  Paul L Bollyky; Marika Bogdani; Jennifer B Bollyky; Rebecca L Hull; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

4.  Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes.

Authors:  Nan Xiao; Zhiping Wang; Yexiang Huang; Firouz Daneshgari; Guiming Liu
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

5.  Cardiovascular Risk and Serum Hyaluronic Acid: A Preliminary Study in a Healthy Population of Low/Intermediate Risk.

Authors:  Chrysanthi Papanastasopoulou; Maria Papastamataki; Petros Karampatsis; Eleni Anagnostopoulou; Ioannis Papassotiriou; Nikolaos Sitaras
Journal:  J Clin Lab Anal       Date:  2016-06-16       Impact factor: 2.352

Review 6.  The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc.

Authors:  Vincent C Hascall; Aimin Wang; Markku Tammi; Sanna Oikari; Raija Tammi; Alberto Passi; Davide Vigetti; Richard W Hanson; Gerald W Hart
Journal:  Matrix Biol       Date:  2014-01-30       Impact factor: 11.583

7.  Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1.

Authors:  Tiina A Jokela; Katri M Makkonen; Sanna Oikari; Riikka Kärnä; Elina Koli; Gerald W Hart; Raija H Tammi; Carsten Carlberg; Markku I Tammi
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

8.  Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.

Authors:  Kirsi Rilla; Sanna Oikari; Tiina A Jokela; Juha M T Hyttinen; Riikka Kärnä; Raija H Tammi; Markku I Tammi
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

Review 9.  Hyaluronan and Its Receptors as Regulatory Molecules of the Endothelial Interface.

Authors:  Kimberly A Queisser; Rebecca A Mellema; Aaron C Petrey
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

10.  Correlative Light and Electron Microscopy Reveals the HAS3-Induced Dorsal Plasma Membrane Ruffles.

Authors:  Kirsi Rilla; Arto Koistinen
Journal:  Int J Cell Biol       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.